 |
Saul A Mashaal, PhMb, MBA
Chairman, Founder and Chief Executive Officer
SciGen Ltd
Chairman SciTech Group
Mr. Mashaal has more than 35 years' experience in the pharmaceutical industry. He started his career with Syntex Laboratories Ltd., (now Roche Bioscience Inc.) in Canada and continued with Syntex International where he was responsible for the management of systemic steroid products. In 1973, Mr. Mashaal joined the 3M Company and was given responsibility for assisting in the creation of a clinical research group and managing the clinical research development of new molecules in the field of non-steroidal anti-inflammatory (NSAID) analgesic and cardiovascular products. In 1976, Mr. Mashaal was given responsibility for International Business Development in the Health and Sciences sector at 3M. In 1980, Mr. Mashaal founded Mashaal Enterprises Ltd, a holding company with interests in healthcare and biotechnology-related companies, for the investment in and development of emerging companies in the fields of health and sciences. In 1987, Mr. Mashaal founded SciTech Medical for the International Market Development of Healthcare Products. In 1988 Mr. Mashaal founded SciGen Ltd (formerly SciTech Genetics) to develop, manufacture and market BioPharmaceuticals. |
| |
| |
|
| |
 |
back |
